Jinsi Msaada Hufanya Kazi
Kuhuisha uzoefu maalum wa duka la dawa kwa mgonjwa wetu kwa urahisishaji wa huduma kamili usio na kifani
1. Angalia Uthibitishaji wa Chanjo/Manufaa
Timu yetu ya watoza bili waliobobea hupata njia bora zaidi za uwasilishaji zinazopunguza gharama za nje ya mfuko.
2. Hamisha Maagizo kwa AmeriPharma®
Tunachakata maagizo yako kwa kufanya kazi na duka lako la dawa au daktari aliyeagiza, kufanya mabadiliko ya haraka na rahisi.
3. Uidhinishaji wa Awali
Timu yetu ya wataalamu hupata idhini kutoka kwa kampuni zako za bima ndani ya saa 24 hadi 72.
4. Msaada wa Copay & Msaada wa Kifedha
Tunapata usaidizi wa kifedha na kupunguza malipo ya nakala, gharama za nje ya mfuko, na makato mengi. Kufikia sasa, AmeriPharma® Specialty Care imepata msaada wa kifedha wa $55 milioni kwa wagonjwa wetu.
5. Uratibu wa Huduma ya Uuguzi Ikihitajika
AmeriPharma® hutanguliza ratiba yako na mazingira ya nyumbani unapopanga na kuratibu mmoja wa wauguzi wetu waliobobea kwa ajili ya uingilizi wako wa nyumbani.
6. Uratibu wa Utoaji
Dawa hutolewa kila wakati kwa kufuata madhubuti na mahitaji maalum ya usafirishaji. Uwasilishaji wa mnyororo baridi wa siku inayofuata na usiku kucha huratibiwa kulingana na ratiba yako.
What Is Zejula?
Zejula (niraparib) is an oral targeted therapy medication used for the treatment of ovarian, fallopian tube, and primary peritoneal cancer. Zejula is a PARP (poly adenosine diphosphate-ribose polymerase) inhibitor that specifically targets cancer cells and exerts less harm on healthy cells in the body. PARP is a protein found in human cells which aids in repairing damaged cells. PARP inhibitors as targeted treatments work by blocking the repair of cancerous cells and allowing them to die.
PARP inhibitors are given to patients after full or partial response to initial chemotherapy with a platinum-based medication. Zejula is used as a maintenance treatment to help prevent cancer from coming back. Zejula is a once-daily oral maintenance medication treatment available in 100 mg capsules that can be taken with or without food.
What is Zejula Used to Treat?
Zejula is FDA approved for adult patients as a maintenance treatment for recurrent maintenance therapy. It is approved for women with advanced ovarian cancer in complete or partial response, such as advanced or recurrent:
- Epithelial ovarian cancer
- Fallopian tube cancer
- Primary peritoneal cancer
Zejula is also used for the treatment of adult patients who have been treated with three or more prior chemotherapy regimens associated with homologous recombination deficiency (HRD) positive status defined by either:
- A harmful or suspected-to-be-harmful BRCA mutation, or
- A genomic instability that progressed more than 6 months after response to the last chemotherapy session.
Zejula Side Effects
Zejula Dosing Information
Zejula is only available in 100 mg capsules, and the recommended dosages are shown below:
First-line Maintenance Treatment for Advanced Ovarian Cancer
For patients who weigh < 77 kg (<170 lbs) OR with a platelet count <150,000/ μL, the recommended dose is 200 mg taken by mouth once a day. For patients who weigh >77 kg (>170 lbs) OR with a platelet count >150.000/ μL, the recommended dose is 300 mg taken by mouth once a day.
Maintenance Treatment for Recurrent Ovarian Cancer
The recommended dose is 300 mg (3 capsules) taken orally once daily.
Treatment of Advanced Ovarian Cancer After Three or More Chemotherapy Regimens
The recommended dose is 300 mg (3 capsules) taken orally once daily.
Zejula can be taken with or without food. Take the medication at approximately the same time each day. Taking the medication at bedtime may help relieve symptoms of nausea.
Treatment with Zejula will require routine monitoring of blood pressure, heart rate, and blood cell count.
Continue Zeluja treatment until disease progression or unacceptable toxicity.
It is not known if Zejula is safe and effective in children.
Zejula can cause fetal harm if administered to pregnant patients. Avoid breastfeeding and use effective contraceptives during treatment and for 6 months after the last dose of Zeluja. If you get pregnant, contact your doctor immediately.
Zejula Side Effects
Common side effects include:
- Mouth sores
- Maumivu ya tumbo
- Constipation or diarrhea
- Kupoteza hamu ya kula
- Urinary tract infections
- Heartburn or indigestion
- Anxiety
- Maumivu ya koo
- Upungufu wa pumzi
- Upele
Other side effects of Zejula include:
- Musculoskeletal pain
- Maumivu ya tumbo
- Kikohozi
- Kukosa usingizi
Madhara makubwa ni pamoja na:
- Bone marrow suppression: Complete blood counts should be monitored weekly for the first month. Patients should inform their prescribers if any of these symptoms occur:
- Udhaifu
- Kuhisi uchovu
- Homa
- Frequent infections
- More bruising or bleeding more easily
- Damu kwenye mkojo
- Cardiovascular effects: Blood pressure and heart rate should be monitored at least weekly for the first two months. Patients should inform their prescribers if any of these symptoms occur:
- Irregular heartbeat
- Shinikizo la damu
- Kikohozi
- Kizunguzungu
- Kichefuchefu
Bima Zimekubaliwa
Tunakubali Medicare, Medicaid ya serikali nyingi, Medi-Cal, Blue Shield, na bima nyingi za kibinafsi. Tupigie ili kujua zaidi kuhusu chanjo yako.
Anza kwa Dakika
Jaza maelezo yako na mmoja wa wataalamu wetu atakupigia simu ASAP.
Unaweza Kuokoa Kiasi Gani?
Ongea na mtaalamu wa usaidizi wa copay
(877) 778-0318
Kwa kuwasilisha, unakubali AmeriPharma's Masharti ya Matumizi, Sera ya Faragha, na Notisi ya Mbinu za Faragha
Swahili
English 
Spanish 
Arabic 
Armenian 
Amharic 
Myanmar 
Korean 
Chinese 
Romanian 
Russian 
Tagalog 
Vietnamese 
Nepali 
Pashto